Vote Scores

Home / Companies / CSPC Innovation Pharmaceutical Co., Ltd. / 8 Apr 2026

Meeting · year to 30 June 202628 filers reporting

CSPC Innovation Pharmaceutical Co., Ltd.: meeting of 8 Apr 2026

Votes reported on Form N-PX, item by item

28 Form N-PX filers reported votes at the CSPC Innovation Pharmaceutical Co., Ltd. meeting of 8 Apr 2026. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

48 vote records from 28 filers. 0 of the 28 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management28 filers100.0% for0.0% against0.0% against management5,382,320 reported shares
2

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

91 vote records from 28 filers. 0 of the 28 filers that marked the item either way voted against management.

35.7% for0.0% against64.3% other0.0% against management28 filers78.3% for21.7% against21.7% against management10,487,983 reported shares, counted once per item in this group
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

53 vote records from 28 filers. 0 of the 28 filers that marked the item either way voted against management.

92.9% for0.0% against7.1% other0.0% against management28 filers99.7% for0.3% against0.3% against management5,658,977 reported shares, counted once per item in this group
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

48 vote records from 28 filers. 0 of the 28 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management28 filers100.0% for0.0% against0.0% against management5,382,320 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

135 vote records from 25 filers. 0 of the 25 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management25 filers100.0% for0.0% against0.0% against management15,720,249 reported shares, counted once per item in this group
6

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

9 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management3 filers100.0% for0.0% against0.0% against management426,711 reported shares, counted once per item in this group

How the largest families voted

Family1. Auditor
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalFor
State Street and SPDRFor
Franklin TempletonFor
Charles SchwabFor
Nuveen and TIAAFor
John Hancock and ManulifeFor
Morgan Stanley, Eaton Vance and CalvertFor
Goldman SachsFor
Northern Trust and FlexSharesFor
BNY MellonFor
Pacific Life fundsFor
VanEckFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the CSPC Innovation Pharmaceutical Co., Ltd. meeting?

28 Form N-PX filers reported votes at the meeting of 8 Apr 2026. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by CSPC Innovation Pharmaceutical Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for CSPC Innovation Pharmaceutical Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing CSPC Innovation Pharmaceutical Co., Ltd. with a meeting date within three days of 8 Apr 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.